相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy
Adam S. Darwich et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021 (2021)
Unusual Distribution Kinetics of Gadoxetate in Healthy Human Subjects Genotyped for OATP1B1: Application of Population Analysis and a Minimal Physiological-Based Pharmacokinetic Model
Michael Weiss et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Ex vivo gadoxetate relaxivities in rat liver tissue and blood at five magnetic field strengths from 1.41 to 7 T
Sabina Ziemian et al.
NMR IN BIOMEDICINE (2021)
Dose-Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs
Daiki Mori et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Measurement of Hepatic ABCB1 and ABCG2 Transport Activity with [11C]Tariquidar and PET in Humans and Mice
Irene Hernandez Lozano et al.
MOLECULAR PHARMACEUTICS (2020)
Inter-compound and Intra-compound Global Sensitivity Analysis of a Physiological Model for Pulmonary Absorption of Inhaled Compounds
Nicola Melillo et al.
AAPS JOURNAL (2020)
Application of PBPK Modeling and Simulation for Regulatory Decision Making and Its Impact on US Prescribing Information: An Update on the 2018-2019 Submissions to the US FDA's Office of Clinical Pharmacology
Xinyuan Zhang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Physiologically Based Pharmacokinetic Modeling in Regulatory Science: An Update From the US Food and Drug Administration's Office of Clinical Pharmacology
Manuela Grimstein et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Comprehensive Evaluation of the Utility of 20 Endogenous Molecules as Biomarkers of OATP1B Inhibition Compared with Rosuvastatin and Coproporphyrin I
Shelby Barnett et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Expanded Physiologically-Based Pharmacokinetic Model of Rifampicin for Predicting Interactions With Drugs and an Endogenous Biomarker via Complex Mechanisms Including Organic Anion Transporting Polypeptide 1B Induction
Ryuta Asaumi et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
Gaining Mechanistic Insight Into Coproporphyrin I as Endogenous Biomarker for OATP1B-Mediated Drug-Drug Interactions Using Population Pharmacokinetic Modeling and Simulation
Shelby Barnett et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
ITC Commentary on Metformin Clinical Drug-Drug Interaction Study Design That Enables an Efficacy-and Safety-Based Dose Adjustment Decision
Maciej J. Zamek-Gliszczynski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Simultaneous Assessment In Vitro of Transporter and Metabolic Processes in Hepatic Drug Clearance: Use of a Media Loss Approach
James Harrison et al.
DRUG METABOLISM AND DISPOSITION (2018)
A Clinical Quantitative Evaluation of Hepatobiliary Transport of [11C] Dehydropravastatin in Humans Using Positron Emission Tomography
Ken-Ichi Kaneko et al.
DRUG METABOLISM AND DISPOSITION (2018)
In Vitro-ln Vivo Extrapolation of OATP1B-Mediated Drug-Drug Interactions in Cynomolgus Monkey
Ayse Ufuk et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
A multi-center preclinical study of gadoxetate DCE-MRI in rats as a biomarker of drug induced inhibition of liver transporter function
Anastassia Karageorgis et al.
PLOS ONE (2018)
Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches
Yingying Guo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter Consortium
Xiaoyan Chu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Successful Prediction of In Vivo Hepatobiliary Clearances and Hepatic Concentrations of Rosuvastatin Using Sandwich-Cultured Rat Hepatocytes, Transporter- Expressing Cell Lines, and Quantitative Proteomics
Kazuya Ishida et al.
DRUG METABOLISM AND DISPOSITION (2018)
Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis
Celine Giraudeau et al.
EUROPEAN RADIOLOGY (2017)
In Vitro-In Vivo Extrapolation of Metabolism- and Transporter-Mediated Drug-Drug Interactions-Overview of Basic Prediction Methods
Kenta Yoshida et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Physiologically Based Pharmacokinetic Modeling of Drug Transporters to Facilitate Individualized Dose Prediction
Aleksandra Galetin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Does the Systemic Plasma Profile Inform the Liver Profile? Analysis Using a Physiologically Based Pharmacokinetic Model and Individual Compounds
Rui Li et al.
AAPS JOURNAL (2016)
Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA
Marios Spanakis et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2016)
Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data
Nikolaos Tsamandouras et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Development and Application of a Mechanistic Pharmacokinetic Model for Simvastatin and its Active Metabolite Simvastatin Acid Using an Integrated Population PBPK Approach
Nikolaos Tsamandouras et al.
PHARMACEUTICAL RESEARCH (2015)
PET Imaging of Oatp-Mediated Hepatobiliary Transport of [11C] Rosuvastatin in the Rat
Jiake He et al.
MOLECULAR PHARMACEUTICS (2014)
Physiologically Realistic and Validated Mathematical Liver Model Revels Hepatobiliary Transfer Rates for Gd-EOB-DTPA Using Human DCE-MRI Data
Mikael Fredrik Forsgren et al.
PLOS ONE (2014)
Reduced Physiologically-Based Pharmacokinetic Model of Repaglinide: Impact of OATP1B1 and CYP2C8 Genotype and Source of In Vitro Data on the Prediction of Drug-Drug Interaction Risk
Michael Gertz et al.
PHARMACEUTICAL RESEARCH (2014)
Response to The Link Between Pharmacodynamics and Physiologically Based Pharmacokinetic Models
A. Rostami-Hodjegan
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Intracellular Drug Concentrations and Transporters: Measurement, Modeling, and Implications for the Liver
X. Chu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
ITC Recommendations for Transporter Kinetic Parameter Estimation and Translational Modeling of Transport-Mediated PK and DDIs in Humans
M. J. Zamek-Gliszczynski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition
Jose L. Ulloa et al.
NMR IN BIOMEDICINE (2013)
Cyclosporine Inhibition of Hepatic and Intestinal CYP3A4, Uptake and Efflux Transporters: Application of PBPK Modeling in the Assessment of Drug-Drug Interaction Potential
Michael Gertz et al.
PHARMACEUTICAL RESEARCH (2013)
A comparison of bootstrap approaches for estimating uncertainty of parameters in linear mixed-effects models
Hoai-Thu Thai et al.
PHARMACEUTICAL STATISTICS (2013)
Effect of Ritonavir on (99m)Technetium-Mebrofenin Disposition in Humans: A Semi-PBPK Modeling and In Vitro Approach to Predict Transporter-Mediated DDIs
N. D. Pfeifer et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Contrast agents as a biological marker in magnetic resonance imaging of the liver: conventional and new approaches
Wieland H. Sommer et al.
ABDOMINAL IMAGING (2012)
A Perspective on Efflux Transport Proteins in the Liver
K. Koeck et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
A LC-MS/MS method to evaluate the hepatic uptake of the liver-specific magnetic resonance imaging contrast agent gadoxetate (Gd-EOB-DTPA) in vitro and in humans
Jia Jia et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
PET Imaging Based Evaluation of Hepatobiliary Transport in Humans with (15R)-11C-TIC-Me
Tadayuki Takashima et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Visualization of Hepatic Uptake Transporter Function in Healthy Subjects by Using Gadoxetic Acid-enhanced MR Imaging
Ali Nassif et al.
RADIOLOGY (2012)
Simultaneous Assessment of Uptake and Metabolism in Rat Hepatocytes: A Comprehensive Mechanistic Model
Karelle Menochet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
The Involvement of Organic Anion Transporting Polypeptide in the Hepatic Uptake of Telmisartan in Rats: PET Studies with [11C]Telmisartan
Tadayuki Takashima et al.
MOLECULAR PHARMACEUTICS (2011)
On the Scope and Interpretation of the Tofts Models for DCE-MRI
Steven P. Sourbron et al.
MAGNETIC RESONANCE IN MEDICINE (2011)
Hepatic Uptake of the Magnetic Resonance Imaging Contrast Agent Gd-EOB-DTPA: Role of Human Organic Anion Transporters
Mirko Leonhardt et al.
DRUG METABOLISM AND DISPOSITION (2010)
Technical aspects of MR perfusion
Steven Sourbron
EUROPEAN JOURNAL OF RADIOLOGY (2010)
Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
Takao Watanabe et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences
Matthias C. Schabel et al.
PHYSICS IN MEDICINE AND BIOLOGY (2008)
分享论文
